Mr. Cahn heads Cahn Medical Ventures. Currently, he is a board observer of TyRx Pharma, Inc., a surgical site infection control company; board chairman of MicroMRI, Inc., an MRI-based imaging company focused on osteoporosis assessment; board observer of Cylex, Inc., a predictive medicine company focused on immune-suppressed patients; board observer at CytoSorbents, a company with hyperfusion therapy for sepsis and kidney disease and CEO of Calretex, LLC, a wound management company.

Previously, he was Senior Vice President at Sanford C. Bernstein & Co., Inc., an independent research and management company purchased by Alliance Capital Management in 2000. On the board of directors, Mr. Cahn served as senior managing director of the research business after being director of research and a securities analyst.

In addition to the boards of companies invested in by CMV, Mr. Cahn serves the advisory board of the Sanford C. Bernstein & Co. Center on Leadership and Ethics at the Columbia Business School, and the board of CEI-PEA (Center for Educational Innovation – Public Education Association). He also chairs the board of the Cahn Fellows Program for Distinguished New York City Principals at Teachers College, Columbia University.

Mr. Cahn graduated from Washington and Lee University and holds an M.B.A. from Columbia University.